Article

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody

2024-07-08

Abstract excerpt

<h4>ABSTRACT</h4> Monoclonal antibodies are widely used for the treatment of infectious human diseases, including COVID-19. Since the start of the pandemic, eight monoclonal antibodies against SARS-CoV-2 were granted emergency use authorization. High mutation rate of the SARS-CoV-2 virus has led to the emergence of highly transmissible variants efficiently evading vaccine-induced immunity. This highlights the imp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9a2fd597-0826-54bb-988a-0eabc23f0333
DOI: 10.1101/2024.07.08.602557

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibodyDOI 10.1101/2024.07.08.602557Read

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity Read

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsSemantic proximity Read

Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable SiteSemantic proximity Read

Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infectionSemantic proximity Read

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administrationSemantic proximity Read

Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster modelsSemantic proximity Read

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingSemantic proximity Read

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodentsSemantic proximity Read

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodiesSemantic proximity Read

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodySemantic proximity Read

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variantsSemantic proximity Read

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsSemantic proximity Read